| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclooxygenase 2 | 11 | 2012 | 483 | 2.110 |
Why?
|
| Proto-Oncogene Proteins c-mos | 14 | 1999 | 16 | 1.040 |
Why?
|
| Oncogene Proteins v-mos | 16 | 1998 | 18 | 0.750 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2016 | 28 | 0.700 |
Why?
|
| Breast Neoplasms | 18 | 2022 | 15694 | 0.670 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2010 | 200 | 0.560 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2016 | 1215 | 0.530 |
Why?
|
| Protein Kinases | 11 | 2007 | 874 | 0.520 |
Why?
|
| Sarcoma Viruses, Murine | 9 | 1992 | 12 | 0.510 |
Why?
|
| Genomic Instability | 2 | 2008 | 519 | 0.490 |
Why?
|
| Moloney murine sarcoma virus | 8 | 1992 | 10 | 0.480 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 215 | 0.450 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 360 | 0.430 |
Why?
|
| Retroviridae Proteins, Oncogenic | 9 | 1992 | 36 | 0.430 |
Why?
|
| Adaptation, Biological | 1 | 2012 | 49 | 0.420 |
Why?
|
| Neoplasm Metastasis | 6 | 2012 | 5112 | 0.420 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2016 | 509 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2008 | 2359 | 0.390 |
Why?
|
| Receptors, CXCR4 | 2 | 2010 | 269 | 0.390 |
Why?
|
| Serine | 4 | 1999 | 388 | 0.360 |
Why?
|
| Vimentin | 4 | 2012 | 253 | 0.360 |
Why?
|
| Mice, Nude | 8 | 2016 | 4307 | 0.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 973 | 0.330 |
Why?
|
| Neoplastic Cells, Circulating | 4 | 2022 | 607 | 0.330 |
Why?
|
| Genes, mos | 4 | 1998 | 4 | 0.310 |
Why?
|
| Bone Neoplasms | 4 | 2008 | 2576 | 0.300 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2014 | 5178 | 0.290 |
Why?
|
| Peptides | 2 | 2010 | 1479 | 0.290 |
Why?
|
| Mice | 29 | 2016 | 34495 | 0.280 |
Why?
|
| Transfection | 7 | 2008 | 2944 | 0.280 |
Why?
|
| Interleukin-11 | 1 | 2006 | 37 | 0.280 |
Why?
|
| 3T3 Cells | 10 | 1999 | 355 | 0.270 |
Why?
|
| Cell Line, Tumor | 10 | 2016 | 14551 | 0.270 |
Why?
|
| Animals | 42 | 2016 | 59536 | 0.260 |
Why?
|
| Glucosamine | 7 | 1982 | 25 | 0.250 |
Why?
|
| Acetylglucosamine | 8 | 1982 | 25 | 0.250 |
Why?
|
| Pyrazoles | 2 | 2010 | 1471 | 0.250 |
Why?
|
| Cell Cycle | 6 | 2007 | 2084 | 0.250 |
Why?
|
| Sulfonamides | 2 | 2010 | 1823 | 0.240 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2011 | 132 | 0.240 |
Why?
|
| Interleukin-8 | 1 | 2006 | 519 | 0.230 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 494 | 0.230 |
Why?
|
| Blotting, Western | 5 | 2014 | 3536 | 0.220 |
Why?
|
| Neoplastic Stem Cells | 2 | 2010 | 1443 | 0.220 |
Why?
|
| Proto-Oncogene Proteins | 8 | 1998 | 2488 | 0.200 |
Why?
|
| Phosphorylation | 16 | 1999 | 4804 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 3981 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 1995 | 1756 | 0.190 |
Why?
|
| Saccharomyces cerevisiae | 7 | 1988 | 621 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2002 | 614 | 0.180 |
Why?
|
| Breast | 1 | 2007 | 1344 | 0.180 |
Why?
|
| Celecoxib | 2 | 2010 | 200 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2007 | 1818 | 0.180 |
Why?
|
| Circulating Tumor DNA | 1 | 2022 | 235 | 0.170 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 10331 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1999 | 611 | 0.170 |
Why?
|
| Candida albicans | 8 | 1982 | 175 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8873 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 1998 | 234 | 0.170 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 161 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2014 | 5395 | 0.160 |
Why?
|
| Retroviridae Proteins | 2 | 1988 | 20 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2014 | 6150 | 0.160 |
Why?
|
| Cell Survival | 2 | 2016 | 3045 | 0.160 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1998 | 129 | 0.160 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 14289 | 0.150 |
Why?
|
| Cell Movement | 1 | 2005 | 2466 | 0.150 |
Why?
|
| Female | 22 | 2022 | 141928 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1999 | 206 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 639 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 3821 | 0.140 |
Why?
|
| Oncogene Proteins, Viral | 2 | 1986 | 133 | 0.140 |
Why?
|
| Cell Line | 11 | 2007 | 5114 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 1998 | 576 | 0.140 |
Why?
|
| Genes, Viral | 2 | 1987 | 202 | 0.130 |
Why?
|
| Dinoprostone | 2 | 2007 | 208 | 0.130 |
Why?
|
| Immunoassay | 2 | 2006 | 216 | 0.130 |
Why?
|
| Cell Transformation, Viral | 4 | 1988 | 138 | 0.120 |
Why?
|
| COS Cells | 3 | 1999 | 377 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2007 | 703 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1995 | 371 | 0.120 |
Why?
|
| Adenocarcinoma | 3 | 2009 | 7789 | 0.110 |
Why?
|
| Doxorubicin | 2 | 2012 | 3005 | 0.110 |
Why?
|
| Metaphase | 2 | 1992 | 107 | 0.110 |
Why?
|
| Humans | 24 | 2022 | 261506 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2010 | 1493 | 0.110 |
Why?
|
| Bone Marrow | 3 | 2010 | 2358 | 0.110 |
Why?
|
| Molecular Sequence Data | 10 | 1996 | 6089 | 0.110 |
Why?
|
| Oogenesis | 2 | 1992 | 71 | 0.110 |
Why?
|
| Precipitin Tests | 5 | 1999 | 329 | 0.100 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 691 | 0.100 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Amino Acid Sequence | 8 | 1996 | 4233 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1143 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.090 |
Why?
|
| Glutamine | 1 | 2012 | 299 | 0.090 |
Why?
|
| Yeasts | 2 | 1980 | 74 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 107 | 0.090 |
Why?
|
| Inflammation | 2 | 2010 | 2522 | 0.090 |
Why?
|
| Oncogenes | 2 | 1995 | 673 | 0.080 |
Why?
|
| Rabbits | 3 | 1998 | 957 | 0.080 |
Why?
|
| Cadherins | 1 | 2012 | 660 | 0.080 |
Why?
|
| Meiosis | 3 | 1998 | 166 | 0.080 |
Why?
|
| Proteins | 3 | 2014 | 1963 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2016 | 1664 | 0.080 |
Why?
|
| Paclitaxel | 2 | 2010 | 1996 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3639 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 249 | 0.080 |
Why?
|
| Viral Proteins | 3 | 1990 | 435 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 810 | 0.080 |
Why?
|
| Oocytes | 4 | 1997 | 414 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 1 | 1986 | 20 | 0.070 |
Why?
|
| Neoplasm, Residual | 2 | 2010 | 1656 | 0.070 |
Why?
|
| Anoikis | 1 | 2007 | 63 | 0.070 |
Why?
|
| Fungal Proteins | 3 | 1988 | 254 | 0.070 |
Why?
|
| Genes | 1 | 1987 | 491 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2008 | 869 | 0.070 |
Why?
|
| Sarcoma, Experimental | 1 | 1986 | 68 | 0.070 |
Why?
|
| Gene Expression | 2 | 2012 | 3570 | 0.070 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2007 | 174 | 0.070 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 568 | 0.070 |
Why?
|
| Enzyme Induction | 5 | 1982 | 249 | 0.070 |
Why?
|
| Phenotype | 2 | 2008 | 6295 | 0.070 |
Why?
|
| Carbohydrate Epimerases | 4 | 1979 | 7 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 423 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 598 | 0.060 |
Why?
|
| Base Sequence | 5 | 1996 | 4917 | 0.060 |
Why?
|
| Glucose | 3 | 1980 | 1248 | 0.060 |
Why?
|
| RNA, Viral | 2 | 1990 | 671 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3343 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 1082 | 0.060 |
Why?
|
| Maturation-Promoting Factor | 5 | 1997 | 22 | 0.060 |
Why?
|
| Quinazolines | 1 | 2009 | 923 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2008 | 726 | 0.060 |
Why?
|
| Rats | 8 | 1993 | 6086 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2005 | 2819 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 4821 | 0.060 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1982 | 25 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2086 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2010 | 11965 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 5159 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 1996 | 3154 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2016 | 5270 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 803 | 0.050 |
Why?
|
| Obesity | 1 | 2014 | 2884 | 0.050 |
Why?
|
| Liquid Biopsy | 1 | 2022 | 158 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1990 | 358 | 0.050 |
Why?
|
| Molecular Weight | 5 | 1989 | 629 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 1058 | 0.050 |
Why?
|
| Xenopus | 2 | 1998 | 219 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 354 | 0.040 |
Why?
|
| Chromatography | 1 | 1999 | 49 | 0.040 |
Why?
|
| Temperature | 4 | 1990 | 506 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1999 | 128 | 0.040 |
Why?
|
| Spheroplasts | 1 | 1979 | 4 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2006 | 2450 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1999 | 231 | 0.040 |
Why?
|
| Disease Progression | 2 | 2007 | 6682 | 0.040 |
Why?
|
| DNA Damage | 1 | 2007 | 1954 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 259 | 0.040 |
Why?
|
| Isoelectric Point | 2 | 1989 | 29 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 4975 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 280 | 0.040 |
Why?
|
| Bone Marrow Examination | 2 | 2008 | 153 | 0.040 |
Why?
|
| Mitosis | 3 | 1998 | 615 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2010 | 7226 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1998 | 198 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1998 | 155 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 80 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1998 | 249 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1998 | 311 | 0.040 |
Why?
|
| Phosphotransferases | 4 | 1980 | 84 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 931 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 217 | 0.030 |
Why?
|
| Peptide Mapping | 3 | 1991 | 114 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 7222 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1995 | 136 | 0.030 |
Why?
|
| Microtubules | 1 | 1997 | 270 | 0.030 |
Why?
|
| Gene Products, gag | 3 | 1990 | 36 | 0.030 |
Why?
|
| Luciferases | 1 | 1996 | 445 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2022 | 1154 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1995 | 160 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1995 | 359 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1998 | 852 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 1991 | 394 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1993 | 266 | 0.030 |
Why?
|
| Genes, env | 1 | 1992 | 11 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1992 | 21 | 0.030 |
Why?
|
| Fusion Proteins, gag-onc | 1 | 1991 | 2 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1980 | 2022 | 0.030 |
Why?
|
| Zygote | 1 | 1991 | 36 | 0.030 |
Why?
|
| Tubulin | 1 | 1992 | 169 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1989 | 568 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 261 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 1991 | 176 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1991 | 205 | 0.020 |
Why?
|
| Invertebrate Hormones | 1 | 1990 | 5 | 0.020 |
Why?
|
| Binding Sites | 2 | 1995 | 2171 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 11538 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 1998 | 4143 | 0.020 |
Why?
|
| Mutation | 4 | 1996 | 15179 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1990 | 521 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 212 | 0.020 |
Why?
|
| Growth Substances | 1 | 1990 | 300 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 2927 | 0.020 |
Why?
|
| Cell Separation | 2 | 2007 | 612 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 1979 | 293 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 15862 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2010 | 342 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1990 | 396 | 0.020 |
Why?
|
| Histidine | 1 | 1988 | 91 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2009 | 388 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1990 | 370 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 1986 | 549 | 0.020 |
Why?
|
| Models, Biological | 1 | 1997 | 3254 | 0.020 |
Why?
|
| Prognosis | 3 | 2011 | 21713 | 0.020 |
Why?
|
| Biological Transport | 2 | 1979 | 597 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 404 | 0.020 |
Why?
|
| Epithelium | 1 | 2009 | 720 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1005 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2008 | 229 | 0.020 |
Why?
|
| Tyrosine | 1 | 1988 | 498 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 3230 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1992 | 1694 | 0.020 |
Why?
|
| Kinetics | 2 | 1980 | 2049 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 298 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 173 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1985 | 47 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 12926 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 1062 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 1986 | 4053 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 1995 | 3101 | 0.020 |
Why?
|
| Sulfhydryl Reagents | 2 | 1980 | 11 | 0.020 |
Why?
|
| Testis | 1 | 1988 | 717 | 0.020 |
Why?
|
| Apoptosis | 1 | 1998 | 7591 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 2216 | 0.010 |
Why?
|
| Furocoumarins | 1 | 1982 | 9 | 0.010 |
Why?
|
| RNA Caps | 1 | 1982 | 34 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1988 | 1555 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1998 | 4638 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2009 | 4078 | 0.010 |
Why?
|
| Cricetinae | 1 | 1982 | 706 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 1682 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1986 | 1152 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 7548 | 0.010 |
Why?
|
| Mastectomy | 1 | 2007 | 1534 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4844 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1980 | 74 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1980 | 300 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1982 | 575 | 0.010 |
Why?
|
| Galactosamine | 1 | 1979 | 8 | 0.010 |
Why?
|
| Acetylgalactosamine | 1 | 1979 | 18 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1980 | 129 | 0.010 |
Why?
|
| Hexosamines | 1 | 1979 | 25 | 0.010 |
Why?
|
| Glucosephosphates | 1 | 1979 | 5 | 0.010 |
Why?
|
| Ethidium | 1 | 1979 | 11 | 0.010 |
Why?
|
| Mitomycins | 1 | 1979 | 48 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1990 | 248 | 0.010 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 1979 | 14 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1979 | 97 | 0.010 |
Why?
|
| Species Specificity | 1 | 1980 | 777 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1979 | 25 | 0.010 |
Why?
|
| Deoxyadenosines | 1 | 1979 | 42 | 0.010 |
Why?
|
| Middle Aged | 3 | 2011 | 86204 | 0.010 |
Why?
|
| Cyclin B1 | 1 | 1998 | 56 | 0.010 |
Why?
|
| Cyclin B | 1 | 1998 | 63 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 198 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1979 | 204 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1990 | 4367 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2007 | 10001 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1995 | 246 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 4757 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1979 | 992 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 12873 | 0.010 |
Why?
|
| Protamine Kinase | 1 | 1992 | 18 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 13658 | 0.010 |
Why?
|
| Viral Fusion Proteins | 1 | 1992 | 85 | 0.010 |
Why?
|
| Bucladesine | 1 | 1990 | 31 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1990 | 57 | 0.010 |
Why?
|
| Spermatocytes | 1 | 1991 | 43 | 0.010 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1990 | 14 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1990 | 65 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1990 | 14 | 0.010 |
Why?
|
| Polymers | 1 | 1992 | 223 | 0.010 |
Why?
|
| Neoplasms | 1 | 1997 | 15193 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1990 | 226 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 600 | 0.010 |
Why?
|
| Granulosa Cells | 1 | 1991 | 146 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1990 | 116 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1990 | 426 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1990 | 227 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 29902 | 0.010 |
Why?
|
| Cyclins | 1 | 1990 | 456 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1990 | 886 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1991 | 769 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 694 | 0.000 |
Why?
|
| Antibodies | 1 | 1990 | 838 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 32848 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1990 | 1764 | 0.000 |
Why?
|
| Amino Acids | 1 | 1990 | 728 | 0.000 |
Why?
|
| Spermatozoa | 1 | 1988 | 315 | 0.000 |
Why?
|
| Male | 3 | 2009 | 123000 | 0.000 |
Why?
|
| Muscles | 1 | 1986 | 416 | 0.000 |
Why?
|
| Immune Sera | 1 | 1985 | 146 | 0.000 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1985 | 110 | 0.000 |
Why?
|
| Protein Binding | 1 | 1992 | 3438 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1990 | 2074 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 70117 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 889 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1990 | 5637 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 77950 | 0.000 |
Why?
|
| Piperazines | 1 | 1990 | 2101 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1980 | 157 | 0.000 |
Why?
|
| Drug Stability | 1 | 1980 | 105 | 0.000 |
Why?
|
| Magnesium | 1 | 1980 | 160 | 0.000 |
Why?
|
| Mannose | 1 | 1979 | 40 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1980 | 585 | 0.000 |
Why?
|
| Culture Media | 1 | 1979 | 319 | 0.000 |
Why?
|
| RNA | 1 | 1979 | 1013 | 0.000 |
Why?
|
| DNA | 1 | 1979 | 2693 | 0.000 |
Why?
|